A&O Shearman, Cooley Guide Merck's $1.3B UK Biotech Deal
Germany's Merck said Monday it has agreed to acquire U.K. biotechnology company Silence Therapeutics PLC at a $1.3 billion equity value, with Allen Overy Shearman Sterling advising Merck and Cooley LLP...To view the full article, register now.
Already a subscriber? Click here to view full article